Association of LPA variants with risk of coronary disease and the implications for Lipoprotein(a)-lowering therapies: a mendelian randomization analysis by Burgess, S, Ference, BA, Staley, JR, Freitag, DF, Mason, AM, Nielsen, SF, Willeit, P, Young, R, Surendran, P, Karthikeyan, S, Bolton, TR, Peters, JE, Kamstrup, PR, Tybjærg-Hansen, A, Benn, M, Langsted, A, Schnohr, P, Vedel-Krogh, S, Kobylecki, CJ, Ford, I, Packard, C, Trompet, S, Jukema, JW, Sattar, N, Di Angelantonio, E, Saleheen, D, Howson, JMM, Nordestgaard, BG, Butterworth, AS, Danesh, J, Key, T, European Prospective Investigation Into Cancer And Nutrition-Cardiovascular Disease (EPIC-CVD) Consortium